WHO defends data after concluding Gilead's remdesivir flopped Covid-19 trial

WHO defends data after concluding Gilead's remdesivir flopped Covid-19 trial Gilead has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the "emerging (WHO) data appears inconsistent". Gilead was given data from the United Nations health agency's trial 10 days ago, to give it an opportunity to react. https://ift.tt/eA8V8J